Kenalog and Fludara drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Kenalog (triamcinolone acetonide) and Fludara (fludarabine phosphate). Common drug interactions include pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Kenalog and Fludara. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Kenalog?

Kenalog has active ingredients of triamcinolone acetonide. It is often used in pain. eHealthMe is studying from 10,692 Kenalog users. Check the latest studies of Kenalog.

What is Fludara?

Fludara has active ingredients of fludarabine phosphate. eHealthMe is studying from 46,686 Fludara users. Check the latest studies of Fludara.

On Jul, 25, 2026

12 people who take Kenalog and Fludara together, and have interactions are studied.

What are the common drug interactions of Kenalog and Fludara, by gender? *:

female:

n/a

male:

Pyrexia (fever)
Mucosal inflammation (infection of mucous membrane)
Rhinovirus infection
Sepsis (a severe blood infection that can lead to organ failure and death)
Skin fissures (a crack in the skin)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Bacteraemia (presence of bacteria in the blood)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Enterococcal bacteraemia (presence of bacteria lactic acid in the blood)
Pneumonia

What are the common drug interactions of Kenalog and Fludara, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Bacteraemia (presence of bacteria in the blood)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Enterococcal bacteraemia (presence of bacteria lactic acid in the blood)
Pneumonia

30-39:

n/a

40-49:

n/a

50-59:

Cough
Febrile neutropenia (fever with reduced white blood cells)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Rhinovirus infection
Sepsis (a severe blood infection that can lead to organ failure and death)
Skin fissures (a crack in the skin)

60+:

Mucosal inflammation (infection of mucous membrane)
Pyrexia (fever)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Neutropenia (an abnormally low number of neutrophils)
Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
Prostate cancer
Corneal abrasion (loss of the surface of cornea)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously)
Rash

What are the existing conditions these people have? *

Bone Marrow Conditioning Regimen: 8 people, 66.67%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 41.67%
Burkitt Lymphoma (cancer of the lymphatic system): 3 people, 25.00%
Non-Hodgkin's Lymphoma Unspecified Histology Indolent (malignant (cancer) cells form in the lymph system- unspecified histology indolent): 2 people, 16.67%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 16.67%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 16.67%
Rashes (redness): 2 people, 16.67%
Skin Disorder (skin disease): 1 person, 8.33%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 8.33%
Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Kenalog and Fludara?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously